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Abstract
Background: Previous research has documented that the symptoms of bipolar disorder are often mistaken for 
unipolar depression prior to a patient's first bipolar diagnosis. The assumption has been that once a patient receives a 
bipolar diagnosis they will no longer be given a misdiagnosis of depression. The objectives of this study were 1) to 
assess the rate of subsequent unipolar depression diagnosis in individuals with a history of bipolar disorder and 2) to 
assess the increased cost associated with this potential misdiagnosis.
Methods: This study utilized a retrospective cohort design using administrative claims data from 2002 and 2003. 
Patient inclusion criteria for the study were 1) at least 2 bipolar diagnoses in 2002, 2) continuous enrollment during 
2002 and 2003, 3) a pharmacy benefit, and 4) age 18 to 64. Patients with at least 2 unipolar depression diagnoses in 
2003 were categorized as having an incongruent diagnosis of unipolar depression. We used propensity scoring to 
control for selection bias. Utilization was evaluated using negative binomial models. We evaluated cost differences 
between patient cohorts using generalized linear models.
Results: Of the 7981 patients who met all inclusion criteria for the analysis, 17.5% (1400) had an incongruent 
depression diagnosis (IDD). After controlling for background differences, individuals who received an IDD had higher 
rates of inpatient and outpatient psychiatric utilization and cost, on average, an additional $1641 per year compared to 
individuals without an IDD.
Conclusions: A strikingly high proportion of bipolar patients are given the differential diagnosis of unipolar depression 
after being identified as having bipolar disorder. Individuals with an IDD had increased acute psychiatric care services, 
suggesting higher levels of relapses, and were at risk for inappropriate treatment, as antidepressant therapy without a 
concomitant mood-stabilizing medication is contraindicated in bipolar disorder. Further prospective research is 
needed to validate the findings from this retrospective administrative claims-based analysis.
Background
Bipolar disorder, a severe and recurrent mental disorder,
is characterized by episodes of elated and depressed
mood. Epidemiological studies have reported lifetime
prevalence ranging from 0.8% - 5.1% [1-3]. However, in
most private claims databases, the prevalence of treated
bipolar disorder has been found to be lower (0.2%) [4,5].
This discrepancy can be attributed to 2 factors: Only 40%
of individuals with bipolar disorder have private insur-
ance [6], and many patients are not correctly diagnosed.
The results of screening studies for bipolar disorder
have shown that a strikingly high proportion of individu-
als seeking treatment for symptoms of bipolar disorder
are not diagnosed. In a recent primary care screening
study, less than 10% of individuals who screened positive
for bipolar disorder on a brief screening tool (Mood Dis-
orders Questionnaire; MDQ) reported being previously
diagnosed with bipolar disorder [7]. In another study that
rigorously confirmed the bipolar diagnosis, 25.6% of psy-
chiatric outpatients with bipolar I and 50.5% with bipolar
II disorder were not diagnosed [8]. Other survey research
found an average time lag between onset of symptoms
and diagnosis of 7-10 years [6,8].
Part of the challenge of recognizing bipolar disorder is
differentiating it from other disorders, particularly non-
bipolar, or unipolar, depression [9], given the high degree
of symptom overlap. The symptoms a bipolar patient
experiences during a depressive episode meet the diag-
nostic criteria for major depressive disorder; the disor-
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ders are differentiated based on the patient's history of
manic or hypomanic symptoms [10]. Unfortunately,
patients often do not recall past manic symptoms or do
not recall them as problematic [11]. Further, depressive
symptoms are present 3 times as often as manic symp-
toms in patients with bipolar disorder [12]. Thus, eliciting
a history of manic or hypomanic symptoms is a difficult
challenge for clinicians. Yet, when such a history remains
unknown, patients are likely to receive a unipolar depres-
sion diagnosis and treatment that is inappropriate or con-
traindicated for bipolar disorder, such as antidepressant
monotherapy and lack of appropriate mood-stabilizing
medication.
Because of the important treatment implications of this
differential diagnosis, efforts have been made to improve
initial identification of bipolar disorder and differentiate
it from unipolar depression. Review articles have
described the subtle clinical characteristics that differen-
tiate not-yet-recognized bipolar disorder from unipolar
depression [13,14]. In addition, screening tools for bipo-
lar disorder, such as the MDQ [15] and a claims-based
screening algorithm [16], have been developed to help
identify unrecognized bipolar disorder.
These efforts assumed that an accurate diagnosis of
bipolar disorder, once achieved, would remain with the
patient throughout future treatment, but our previous
research suggests that an initial diagnosis of bipolar dis-
order may be less stable than previously thought. We
found that 27.5% of individuals initially diagnosed with
bipolar disorder received unipolar depression disorder
diagnoses after they had been diagnosed with bipolar dis-
order [17,18]. Those patients who had received incongru-
ent depression diagnoses (IDDs) had an 82% increase in
mental health hospitalizations, a 147% increase in mental
health emergency room (ER) visits, and an 80% increase
in mental health ambulatory visits, resulting in an
increase of $3189 per patient per year in treatment costs
relative to those patients who were not given the incon-
gruent unipolar depression diagnosis. Analysis of pro-
vider switching revealed that the lack of continuity of care
among mental health providers was the most convincing
mechanism for the loss of the bipolar diagnosis.
Our earlier study [18], selected a population of individ-
uals who had been newly diagnosed with bipolar disorder
in their administrative claims. However, a health manage-
ment intervention study to validate those findings would
be simpler to implement and potentially have larger cost
savings if conducted in the larger population of all indi-
viduals with a diagnosis of bipolar disorder, rather than
just those newly diagnosed. This potential intervention
could start on a given date, examine all individuals with a
history of a bipolar diagnosis, screen for new claims with
depression diagnoses from a different healthcare pro-
vider, and then intervene to inform the provider of the
previous bipolar disorder diagnosis. Identifying the best
population to intervene in is of paramount concern for
designing a health management intervention.
The objectives of the current study were to identify the
costs of an incongruent diagnosis by expanding the study
population from initially diagnosed bipolar patients to all
bipolar patients. Specifically, we assessed the rate of IDDs
given to individuals with a history of bipolar disorder as
of January 1, 2003 and assessed the increased costs asso-
ciated with the IDD. We intend to inform the design and
population for a potential intervention by analyzing this
study population with similar methods from our prior
research.
Methods
This study design used retrospective, longitudinal claims
data from a large, national, managed-care organization
providing coverage for inpatient care, ambulatory ser-
vices, and prescription drugs. The study sample was
derived from commercially insured health plan members
or members with Medicaid managed-care coverage, 18 to
64 years of age, who had medical and pharmacy benefits,
and who were continuously enrolled in the health plan
from January 1, 2002 until December 31, 2003. The data
were used with permission from the data source. Individ-
uals may not have had continuous enrollment during the
study period for a variety of reasons including, but not
limited to, a loss of employment, a switch in employers,
an employer's switching of insurance companies, failure
to pay insurance premiums, discontinuation of insurance
coverage, or death. Study patients were required to have a
minimum of 2 bipolar diagnoses in 2002. Because we
used a prevalence-based sample rather than patients
newly diagnosed, the index date was set to January 1,
2003 for all patients. With the exception of the definition
of the index date and the precise time period for continu-
ous enrollment, the study methods and variable defini-
tions mirror those of our previously published study [18].
To control for background differences between IDD
and no incongruent depression diagnosis (NIDD)
patients, predicted probabilities were used as a covariate
in the outcome models [19]. The predicted probabilities
were calculated from a backward elimination logistic
regression predicting IDD status based on variables mea-
sured in the baseline period. Backward elimination was
used to identify the covariates and to reduce the potential
for bias from multicollinearity and endogeneity. The
independent variables in the model were measured dur-
ing the baseline period and are listed in Table 1.
N e g a t i v e  b i n o m i a l  r e g r e s s i o n  m o d e l s  w e r e  u s e d  t o
investigate the differences in the number of mental health
providers, general practitioners (GPs), and other provid-
ers in the follow-up period across the 2 cohorts, control-
ling for baseline covariates, including the number ofStensland et al. BMC Psychiatry 2010, 10:39
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Table 1: Descriptive statistics: demographic, utilization, and cost variables
Cohort
NIDD (N = 6581) IDD (N = 1400) Uni- variate Multivariate
Demographic Variables: pp
Men, n, % 2378 36.13% 391 27.93% <.0001
Age, mean, SD 40.62 11.02 39.73 10.97 .0064 .0317
Region
Northeast, n, % 747 11.35% 213 15.21% <.0001
South, n, % 2781 42.26% 570 40.71% .2879 .0845
West, n, % 860 13.07% 159 11.36% .0816
Midwest, n, % 2193 33.32% 458 32.71% .6605
Plan Type
Commercial, n, % 6232 94.70% 1344 96.00% .0437
Medicaid, n, % 349 5.30% 56 4.00% .0437
Baseline Variables:
Baseline Unipolar Dx, n, % 886 13.46% 936 66.86% <.0001 <.0001
Number of Unipolar Dxsa 0.95 3.24 8.96 11.60 <.0001 <.0001
Total Costsa 9056.62 18371.86 13448.57 20021.63 <.0001 .0163
M H Ambulatory Costa 835.59 1704.91 1999.31 4421.06 <.0001 <.0001
Non-MH Ambulatory Costa 2089.39 4000.50 2835.56 5239.78 <.0001 .0652
Mental Health ER Costa 48.42 304.59 96.40 525.63 .001
Non-MH ER Costa 206.93 845.65 293.98 1041.55 .0034
MH Inpatient Costa 793.66 3428.65 2141.36 7325.41 <.0001
Non-MH Inpatient Costa 1752.31 17979.46 1658.32 12441.45 .8141
MH Medication Costa 1745.42 1909.65 2153.20 2032.10 <.0001 .018
Total Medication Costa 2836.37 2882.69 3545.40 3370.89 <.0001
Number of Psychotherapy Sessionsa 5.92 9.43 13.14 13.77 <.0001
Antidepressant Day Supplya 186.58 196.25 276.30 209.07 <.0001 <.0001
Lithium Day Supplya 55.36 111.00 31.05 81.58 <.0001 <.0001
Benzodiazepine Day Supplya 64.38 123.73 98.61 144.33 <.0001 .0015
Anticonvulsants Day Supplya 137.94 171.75 132.97 162.30 .3035 <.0001
Antidepressant Monotherapyb 0.082 0.27 0.10 0.30 .031 .0163
Number of Claims w/ADHD Dxa 0.21 1.51 0.29 2.14 .2126 .0716
Number of Claims with Non-MH Unique 
Dxa
12.62 9.38 15.32 10.47 <.0001 .0403
Index BP Dx on Inpatient Claim, n, % 312 4.74% 163 11.64% <.0001 <.0001
BP Diagnosis on ER Claim, n, % 273 4.15% 28 2.00% .0001 .0225
Index BP Dx Mixed Episode, n, % 1208 18.36% 222 15.86% .0269 .0584
Index BP Dx Unspecified Episode, n, % 3020 45.89% 574 41.00% .0008 .0094
Charlson Comorbidity Indexa 0.51 1.14 0.58 1.19 .042
aIn the 1-year period prior to index bipolar disorder diagnosis, mean, SD.
bPatients treated with antidepressant monotherapy were coded 1; those who were not treated with antidepressant monotherapy were coded 0, 
mean, SD.
NIDD = no incongruent depression diagnosis; IDD = incongruent depression diagnosis; SD = standard deviation; Dx = diagnosis; MH = mental 
health; ER = emergency room; ADHD = attention deficit/hyperactivity disorder; BP=bipolarStensland et al. BMC Psychiatry 2010, 10:39
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providers (mental health, GP, other) in the baseline
period. Health care utilization was estimated using nega-
tive binomial models. Two-part models were used to ana-
lyze the relationship between IDD and health care costs.
These models deal with the unique characteristics of
medical expenditure data, which are typically skewed and
censored. The first step was to estimate whether individ-
uals had any medical expenditures using logistic regres-
sion. In the second step, a generalized linear model
(GLM) was used to estimate positive costs. GLMs
account for non-constant variance and maintain the orig-
inal scale of the data, thus eliminating the need to trans-
form cost data to achieve homoskedasticity and the need
to retransform using a Duan smearing estimator for
interpreting results [20]. The results of the 2-part model
were combined to predict medical expenses for an indi-
vidual by multiplying the prediction from each part of the
model (the probability of positive expenses times the pre-
dicted medical expense from the GLM specification) [21].
To integrate the 2-part model, we first derived pre-
dicted cost estimates by running 2 prediction models: the
first assuming the entire sample had an IDD and the sec-
ond assuming the entire sample did not. We then calcu-
lated predicted probabilities of health care utilization.
Predicted costs were combined with predicted probabili-
ties of having any resource utilization (to account for
individuals with 0 visits and 0 costs).
To specify the cost models, we used a variant of the
Park test to determine the appropriate GLM distribution
and link function [22]. The gamma distribution with a
log-link function was used to estimate positive costs. We
calculated robust standard errors using the Huber-
White-type correction for the variance-covariance
matrix of the parameter estimates.
The administrative claims data were statistically de-
identified and compliant with the provisions of the
Health Insurance Portability and Accountability Act
(HIPPA) of 1996 standards. Therefore, this study did not
require Institutional Review Board review.
Results
A total of 7981 patients diagnosed with bipolar disorder
met all inclusion criteria for the analysis (see Figure 1). Of
these patients, 1400 (17.5%) were classified as having an
IDD in the follow-up period. Approximately 66.9% (936/
1400) of patients with an IDD and 13.5% (886/6581) of
patients with NIDD in the follow-up period had a unipo-
lar depression diagnosis during the baseline period.
Descriptive statistics and statistical analyses of means
and proportions on select variables for the 2 cohorts are
shown in Table 1. A backward elimination logistic regres-
sion using the baseline variables from Table 1 to predict
the likelihood of receiving an IDD in the follow-up period
was relatively accurate. The area under the ROC curve
indicates that the background variables were able to accu-
rately classify a randomly selected individual according to
IDD status 84% of the time. Presence of a unipolar
depression diagnosis in the baseline period was a particu-
larly strong predictor (Odds Ratio = 4.6) of a depression
diagnosis in the follow-up period.
We analyzed the specialties of health care providers
giving the first unipolar depression diagnosis (of the 2
required for our definition of incongruent diagnosis) to
see if they differed from the specialties of health care pro-
viders who gave the first diagnosis of bipolar disorder in
the baseline period. Within the IDD cohort, 1046 patients
(74.1%) received their bipolar disorder diagnosis from a
mental health provider. Surprisingly, an even greater
number of patients (1144, 81.7%) received the first of the
2 defined unipolar depression diagnoses from mental
health providers; 93 patients (6.6%) received this first uni-
polar diagnosis from GPs, and 163 (11.6%) from other
providers (hospitals, internal medicine, emergency medi-
cine, or unknown). In 1070 cases (76.4%), the physician
giving the IDD had not previously diagnosed the patient
with bipolar disorder.
The number of health care providers seen by patients in
the follow-up period differed significantly between
patient cohorts. IDD patients saw an average of 2.4 (stan-
dard deviation [SD] = 1.7) mental health care providers
versus 1.2 (SD = 1.2) for NIDD patients (p = .001). After
controlling for predicted probability and number of men-
tal health practitioners in 2002, the number of visits with
a mental health care provider was 1.83 times greater for
IDD than for NIDD patients. Similar results were found
Figure 1 Patient flow.
43,820 individuals had at 
least 1 bipolar claim 
during the identification 
period
14,580 had only 1 bipolar disorder diagnosis
275 were 65 years of age or older
1768 were under age 18
18,229 did not meet the continuous enrollment criteria
614 had Medicare coverage
373 did not have  2 bipolar disorder diagnoses independent 
of a unipolar depression or schizophrenia diagnosis
7981 individuals with bipolar disorder 
met all inclusion criteria
1400 individuals had an 
incongruent unipolar depression 
diagnosis in 2003
6581 individuals had no 
incongruent unipolar depression 
diagnosis in 2003Stensland et al. BMC Psychiatry 2010, 10:39
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for general practitioners (IDD: 1.4 ± 1.6; NIDD: 1.2 ± 1.3;
p = .003, Relative risk [RR] = 1.14) and for all other practi-
tioners (IDD: 7.8 ± 7.6; NIDD: 5.7 ± 5.9; p = .001, RR =
1.13).
IDD patients had significantly more ambulatory mental
health visits, inpatient mental health visits, and ER men-
tal health visits in the follow-up period compared to
NIDD patients (see Table 2) after controlling for baseline
covariates. The RRs from the models indicated that the
average number of mental health ambulatory visits was
1.74 times higher for IDD patients than for NIDD
patients. The mean number of mental health hospital vis-
its and ER visits were 3.06 and 2.06 times greater, respec-
tively, for the IDD patients. In addition, IDD patients'
mental health ambulatory visits were 73% more expen-
sive (see Table 3).
Figure 2 shows the cost differences for the various com-
ponents based on this integration of the 2-part model.
The largest cost difference between the 2 cohorts is for
inpatient mental health care ($1365 for IDD; $608 for
NIDD; difference of $757). If all patients in the study
received an incongruent diagnosis, average total treat-
ment costs per person per year would be $10,773. If
patients did not have the IDDs, average total treatment
costs would be $9132. Thus, the treatment costs associ-
ated with an IDD were $1641 per person per year.
Discussion
This study replicates our previous finding that a mean-
ingful proportion of individuals with a bipolar diagnosis
were given a subsequent incongruent unipolar depression
diagnosis and had increased treatment costs. These
results extend our previous finding from initially diag-
nosed to all bipolar patients. In 2003, 17.5% (1400/7981)
of individuals who had been previously diagnosed with
bipolar disorder were diagnosed with unipolar depres-
sion, a differential diagnosis. Diagnostic criteria indicate
that once a person exhibits symptoms of mania or hypo-
mania that person has bipolar disorder; all future depres-
sive symptoms are part of the bipolar disorder rather than
unipolar depression [10]. The IDDs were associated with
a $1641 increase in treatment costs per patient, after cor-
recting for background differences.
Given that patients were not randomized to be given a
misdiagnosis of unipolar depression in a controlled study,
we cannot be certain that the increased costs were due to
the apparent misdiagnoses. For obvious practical and
ethical reasons, one cannot complete a controlled study
in which participants are randomized to be misdiag-
nosed. Although we corrected for background differences
between the groups on January 1, 2003, we cannot be cer-
tain that the differences between groups in 2003 were due
to the IDDs that occurred during 2003. The individuals
with IDDs may have simply had more health care interac-
tions in 2003 and therefore more opportunity for an
incongruent diagnosis and increased costs. However, we
find the misdiagnoses explanation more plausible for a
variety of reasons.
The pattern of increased treatment costs is indicative of
greater psychiatric relapses (see Figure 2). The 3-fold
increase in rate of psychiatric hospitalization and 2-fold
i n c r e a s e  i n  p s y c h i a t r i c  E R  v i s i t s  ( s e e  T a b l e  2 )  s t r o n g l y
suggest that the individuals who receive the IDDs have
more psychiatric relapses. The increased psychiatric out-
patient and medication costs that would be expected for
individuals experiencing relapses are also observed,
although these costs are more difficult to interpret as they
can increase for other reasons as well, such as individuals
becoming more engaged in treatment.
Table 2: Average number of visits by incongruent depression diagnosis in 2003
Cohort
NIDD IDD
Visit Type Predicted Mean Predicted Mean RRa p
MH Ambulatory 6.57 11.46 1.74 <.0001
Non-MH Ambulatory 10.08 10.56 1.05 .22
MH Hospital 0.27 0.56 3.06 <.0001
Non-MH Hospital 0.11 0.12 1.16 .26
MH ER 0.06 0.19 2.06 <.0001
Non-MH ER 0.61 0.73 1.20 .17
aRelative risk of increased visits for IDD cohort relative to NIDD cohort after correcting for background differences.
NIDD = no incongruent depression diagnosis; IDD = incongruent depression diagnosis; RR = relative risk; MH = mental health; ER = emergency 
roomStensland et al. BMC Psychiatry 2010, 10:39
http://www.biomedcentral.com/1471-244X/10/39
Page 6 of 8
When a patient with bipolar disorder is misdiagnosed
with unipolar depression, the resulting treatment will
likely be contraindicated. The primary pharmacologic
treatment for unipolar depression is antidepressant
monotherapy. Well-controlled clinical trials have found
that antidepressant monotherapy, particularly with tricy-
clic antidepressants, in patients with bipolar disorder can
induce mania at a higher rate than placebo [23]. Further,
unipolar depression is generally not treated with mood-
stabilizing medications, which represent the hallmark of
treatment for bipolar disorder. Thus, appropriate phar-
macologic treatment and control of symptoms depend on
an accurate diagnosis of the patient's bipolar disorder.
Analysis of the number of providers and provider
switching supports the notion that IDDs result, in part,
from continuity of care issues as patients with this epi-
sodic and diagnostically challenging disorder interact
with the health care system. Individuals receiving IDDs
had twice as many mental health providers as those who
did not receive IDDs. Furthermore, in 76% of the cases,
the provider who gave the first incongruent unipolar
depression diagnosis had not previously given the patient
a bipolar diagnosis. Continuity of care may be especially
important for patients with bipolar disorder, because they
often do not recall manic symptoms or do not recall them
as problematic [11]. Given that less than half of patients
discharged after medical hospitalization are able to cor-
rectly state their diagnosis [24] and that medical records
are often not received when requested [25], the physician
giving the IDD may not have information concerning the
patient's previous manic or hypomanic symptoms, espe-
cially when the patient is new to the physician's practice.
Interestingly, the providers making the IDD were gen-
erally mental health specialists (psychiatrists [47.7%],
psychologists [12.8%], social workers [20.5%], other men-
tal health personnel [0.71%]). We would expect that most
of these individuals are well educated about the symp-
toms and presentation of bipolar disorder, which suggests
that this rate of IDDs results from the daunting task of
differentiating the 2 disorders at a given point in time
rather than a lack of knowledge about bipolar disorder. In
the absence of information about past manic symptoms, a
diagnosis of the more prevalent unipolar depression is
more reasonable.
Given that mental health providers made the majority
of IDDs, educational efforts to increase the awareness of
the symptoms and presentation of bipolar disorder would
Table 3: Cost per patient by cohort for individuals who used the resource type
Cohort Cohort
IDD NIDD IDD NIDD








Total Cost (N = 7900) $10,773 $ 9132 1.18 .005
MH Ambulatory (N = 6249) 1422 821 1.73 <.0001 0.96 0.74
Non-MH Ambulatory (N = 7332) 2462 2664 0.92 .34 0.94 0.91
MH Hospital (N = 589) 9491 7837 1.00 .97 0.18 0.05
Non-MH Hospital (N = 675) 15,704 14,841 1.06 .77 0.10 0.08
MH Emergency Room (N = 644) 658 644 1.02 .88 0.12 0.07
Non-MH Emergency Room (N = 1509) 1100 1045 1.05 .68 0.23 0.18
Mental Health Prescription (N = 7014) 2272 2299 0.99 .75 0.95 0.86
Total Prescription (N = 7679) 3522 3454 1.02 .59 0.98 0.96
aRelative risk of increased costs for IDD cohort relative to NIDD cohort after correcting for background differences.
Note: Generalized Linear Models with Log Link Specification
NIDD = no incongruent depression diagnoses; IDD = incongruent depression diagnoses; MH = mental health
Figure 2 Differences in cost components for individuals with in-
congruent depression diagnosis.Stensland et al. BMC Psychiatry 2010, 10:39
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probably only minimally reduce the rate of IDDs. On the
other hand, education about the high rates of IDDs and
the risk factors associated with them may be more effec-
tive in this provider population. To be effective, an inter-
vention needs to result in the current physician receiving
and incorporating information about the past bipolar
diagnosis or symptoms into the current diagnosis.
Limitations
This research utilized administrative claims data, which
enabled the unobtrusive observation of usual clinical
practice for a large number of individuals, a necessary
condition for this research. However, administrative
claims data have limitations given that the data was col-
lected for reimbursement rather than research purposes.
As a result, the measures in the data are not ideal, and the
study design is limited to statistical rather than experi-
mental control, leaving the data open to alternative expla-
nations.
The diagnostic information in claims data may not be
reliable. For some conditions, such as Alzheimer's disease
[26] and myocardial infarction [27], claims diagnosis
algorithms have been found to have high agreement with
medical charts; however, the predictive value of our algo-
rithm from claims diagnoses for bipolar disorder has not
been demonstrated. Unützer and colleagues [5] con-
ducted a chart review of individuals identified as having
bipolar disorder based on various criteria in administra-
tive claims and reported using an unspecified standard
that a "reasonable" number of individuals with at least 1
inpatient discharge diagnosis or outpatient diagnosis had
evidence of bipolar disorder in his or her medical chart.
Our algorithm, which was more restrictive than the sim-
pler criteria studied by Unützer and colleagues, required
at least 2 diagnoses from hospital or physician visits that
did not have exclusionary diagnoses and, therefore,
should be at least "reasonably" accurate. However, even if
the diagnoses in the claims match those in the patients'
charts, they still may not coincide with the diagnoses
m a d e  b a s e d  o n  t h e  g o l d  s t a n d a r d  S t r u c t u r e d  C l i n i c a l
Interview for DSM-IV (SCID). Nonetheless, we believe
our study population is representative, and our results
can be generalized to similar populations.
Throughout this article, we have referred to the depres-
sion diagnoses following bipolar diagnoses as incongruent
diagnoses rather than misdiagnoses. This has been in rec-
ognition that the diagnoses given in the claims may not
reflect the true gold standard SCID diagnoses. In a recent
study examining SCID diagnoses in outpatients, Zim-
merman and colleagues found that less than half (43.4%)
of individuals reporting having been diagnosed with
bipolar disorder met the SCID criteria for the disorder
[28]. Interestingly, 30% of those that did meet the SCID
diagnosis had not previously been diagnosed with bipolar
disorder. These findings suggest that not only is bipolar
often under-diagnosed it is also over-diagnosed. This
raises the possibility that the IDD in our study may have
been the correct diagnosis. However, given the pattern of
resource utilization, we believe that the bipolar disorder
diagnosis was more likely to correct on average. Previous
research in private payer claims has found that bipolar
disorder is more costly than unipolar depression, particu-
larly in terms of psychotropic medication and psychiatric
hospitalization costs [29]. If the unipolar depression diag-
noses had been correct more often than the bipolar, we
would have anticipated the IDD group to have lower,
instead of higher, resource use, particularly for psychiat-
ric hospitalization.
One potential alternative explanation for our results is
individuals who received the IDD following a bipolar
diagnosis were simply more complex patients who, to no
surprise, incurred higher costs. In the analysis, we uti-
lized predicted probabilities to statistically control for
background differences between the IDD and NIDD
patients. A large number of baseline variables were used
to construct the predicted probabilities (Table 1). From a
theoretical perspective, because these variables were used
to calculate the predicted probabilities and the analysis
adjusted for predicted probabilities, the difference
between the IDD and NIDD could not have been driven
by these background differences [19]. To the extent that
these background variables, including costs, comorbidi-
ties, and resource use, capture patient "complexity", we
have ruled out this as a driver of the result. However, if
another confounding variable exists that was not
included in the predicted probability calculation, it could
still explain our results. A study of an intervention in
which administrative claims are screened and physicians
are contacted when they file a claim with an IDD is
needed to validate our results and accurately assess the
cost savings that could be realized.
Conclusions
An incongruent diagnosis of unipolar depression in per-
sons previously identified with bipolar disorder appears
to be relatively frequent and costly. Patients who received
IDDs had increased psychiatric hospitalizations, ER vis-
its, and ambulatory services. The apparent misdiagnosis
may have resulted in patients not receiving the needed
mood-stabilizing medications or receiving contraindi-
cated antidepressant monotherapy. In this study, the
IDDs appeared to arise when patients with bipolar disor-
der switch mental health providers, and the new provider
may not be receiving information about past manic/
hypomanic episodes needed to differentiate bipolar dis-
order from unipolar depression. This retrospective
claims-based analysis needs to be validated with a pro-
spective health management intervention study where an
intervention occurs when an IDD is given to an individual
who was historically diagnosed with bipolar disorder by a
different provider. An effective intervention that informs
a physician who submits a claim with a depression diag-Stensland et al. BMC Psychiatry 2010, 10:39
http://www.biomedcentral.com/1471-244X/10/39
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nosis for a patient about the patient's previous treatment
for bipolar disorder could potentially improve patient
care and save, on average, $1641 per patient per year in a
managed-care population.
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